These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35383489)

  • 1. Editorial Comment: Is It Time to Focus on LR-M?
    Magnetta MJ
    AJR Am J Roentgenol; 2022 Sep; 219(3):433. PubMed ID: 35383489
    [No Abstract]   [Full Text] [Related]  

  • 2. Using MRI to Assess Microvascular Invasion in Hepatocellular Carcinoma.
    Tang A
    Radiology; 2020 Dec; 297(3):582-583. PubMed ID: 32996872
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial comment: advances in the evaluation of liver imaging and function with gadoxetic acid-enhanced MRI.
    Grieser C
    Eur Radiol; 2021 Nov; 31(11):8374-8375. PubMed ID: 34424395
    [No Abstract]   [Full Text] [Related]  

  • 4. Comment on "State of the art in magnetic resonance imaging of hepatocellular carcinoma": the role of DWI.
    Granata V; Fusco R; Filice S; Incollingo P; Belli A; Izzo F; Petrillo A
    Radiol Oncol; 2019 Jul; 53(3):369-370. PubMed ID: 31318697
    [No Abstract]   [Full Text] [Related]  

  • 5. How to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-cholangiocarcinoma on gadoxetate-enhanced MRI?
    Lee HS; Kim MJ; An C
    Eur Radiol; 2019 May; 29(5):2408-2416. PubMed ID: 30552477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial Comment: An Algorithm to Distinguish Between Hepatocellular Adenoma Subtypes on Gadoxetate Disodium-Enhanced MRI.
    Do RKG
    AJR Am J Roentgenol; 2023 Apr; 220(4):549. PubMed ID: 36222489
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver imaging reporting and data system v2014 categorization of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: Comparison with multiphasic multidetector computed tomography.
    Joo I; Lee JM; Lee DH; Ahn SJ; Lee ES; Han JK
    J Magn Reson Imaging; 2017 Mar; 45(3):731-740. PubMed ID: 27474328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging.
    Jeon SK; Joo I; Lee DH; Lee SM; Kang HJ; Lee KB; Lee JM
    Eur Radiol; 2019 Jan; 29(1):373-382. PubMed ID: 29955948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy response assessment after radioembolization of patients with hepatocellular carcinoma--comparison of MR imaging with gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid and gadobutrol.
    Schelhorn J; Best J; Reinboldt MP; Gerken G; Ruhlmann M; Lauenstein TC; Antoch G; Kinner S
    J Vasc Interv Radiol; 2015 Jul; 26(7):972-9. PubMed ID: 25937296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of prospective application of the Liver Imaging Reporting and Data System (LI-RADS) in gadoxetate-enhanced MRI.
    Kim YY; An C; Kim S; Kim MJ
    Eur Radiol; 2018 May; 28(5):2038-2046. PubMed ID: 29230525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis after Curative Resection of Single Hepatocellular Carcinoma with A Focus on LI-RADS Targetoid Appearance on Preoperative Gadoxetic Acid-Enhanced MRI.
    Moon JY; Min JH; Kim YK; Cha D; Hwang JA; Ko SE; Choi SY; Yun EJ; Kim SW; Won HJ
    Korean J Radiol; 2021 Nov; 22(11):1786-1796. PubMed ID: 34402243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LI-RADS v2014 categorization of hepatocellular carcinoma: Intraindividual comparison between gadopentetate dimeglumine-enhanced MRI and gadoxetic acid-enhanced MRI.
    Song JS; Choi EJ; Hwang SB; Hwang HP; Choi H
    Eur Radiol; 2019 Jan; 29(1):401-410. PubMed ID: 29922928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver Imaging Reporting and Data System v2014 With Gadoxetate Disodium-Enhanced Magnetic Resonance Imaging: Validation of LI-RADS Category 4 and 5 Criteria.
    Choi SH; Byun JH; Kim SY; Lee SJ; Won HJ; Shin YM; Kim PN
    Invest Radiol; 2016 Aug; 51(8):483-90. PubMed ID: 26885632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Based on Gadolinium Ethoxybenzyl DTPA-Enhanced MRI: Diagnostic Performance of the Category-Modified LR-5 Criteria in Patients At Risk for Hepatocellular Carcinoma.
    Li S; Deng K; Qiu J; Wang P; Yin D; Xie Y; Yu Y
    Technol Cancer Res Treat; 2024; 23():15330338241256859. PubMed ID: 38780516
    [No Abstract]   [Full Text] [Related]  

  • 15. Inter-reader agreement and imaging-pathology correlation of the LI-RADS M on gadoxetic acid-enhanced magnetic resonance imaging: efforts to improve diagnostic performance.
    Lim K; Kwon H; Cho J
    Abdom Radiol (NY); 2020 Aug; 45(8):2430-2439. PubMed ID: 32008112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy for macroscopic classification of nodular hepatocellular carcinoma: comparison of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and angiography-assisted computed tomography.
    Tada T; Kumada T; Toyoda H; Ito T; Sone Y; Okuda S; Ogawa S; Igura T; Imai Y
    J Gastroenterol; 2015 Jan; 50(1):85-94. PubMed ID: 24563123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
    Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
    AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial Comment: LI-RADS LR-2 and LR-3 Observations-Benign or Not Benign?
    Tang A
    AJR Am J Roentgenol; 2022 Mar; 218(3):471. PubMed ID: 34730386
    [No Abstract]   [Full Text] [Related]  

  • 19. Comment on "Predictors of changes in preoperative tumor stage between dynamic computed tomography and gadoxetate disodium-enhanced magnetic resonance imaging for hepatocellular carcinoma".
    Gong L; Pan L
    J Formos Med Assoc; 2022 Dec; 121(12):2656-2657. PubMed ID: 35999157
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial for "Visualization Score of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging: The Effect on the Diagnostic Accuracy for Hepatocellular Carcinoma".
    Kobayashi S; Ohno N; Kozaka K
    J Magn Reson Imaging; 2023 Mar; 57(3):950-951. PubMed ID: 35856298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.